Preliminary Agenda for the 2022 Cannabinoids in Clinical Practice Conference
| DAY 1 : Thursday April 21, 2022 | ||
| 8:00-9:00 | Breakfast | |
| 9:00-9:15 | Introductions and CCIC Update | Matthew Hill, CCIC Executive Director |
| SESSION 1: Basics and Biology of Cannabinoids and the Endocannabinoid System | ||
| Chair: | ||
| 9:15-10:00 | Growing Our Understanding of Minor Cannabinoid and Terpenoid Pharmacology | Robert Laprairie, PhD |
| 10:00-10:30 | The Impact of Sex on Acute Cannabis Effects and Pharmacology | Justin Matheson, PhD |
| 10:30-11:00 | Health and Coffee Break | |
| 11:00-11:30 | Cannabidiol Pharmacology and Utility | Ruth Ross, PhD |
| Trainee Research Spotlight Awards | ||
| 11:30-11:45 | Cell adhesion molecule 2 deletion reduces impulsivity and voluntary cannabinoid intake, and impairs physiological response to THC in mice | Hayley Thorpe, PhD Candidate |
| 11:45-12:00 | Plasma Endocannabinoid Levels and Cannabis Use in Female Adolescents with Repetitive Non-suicidal Self-injurious Behavior and Trauma | Marc Ferger, 4th Year Medical Student |
| 12:00-13:00 | Lunch | |
| SESSION 2: Non-Medical Cannabis Use and Health Impacts | ||
| Chair: | ||
| 13:00-13:45 | Adolescent Cannabis Use: Where Does the Data Stand? | Matthew Hill, PhD |
| 13:45-14:15 | Cannabis and Psychosis | Jibran Khokhar, PhD |
| 14:15-15:45 | Poster Session | |
| 15:45-16:15 | Variation in Cannabis Pharmacokinetics and Pharmacodynamics by Route of Administration and Product Type | Ryan Vandrey, PhD |
| 16:15-16:30 | Pulmonary Effects of Cannabis | Jeremy Hirota, PhD |
| 16:30-16:45 | Cannabis Hyperemesis Syndrome and Preclinical Probe of Mechanisms | Linda Parker, PhD |
| Trainee Research Spotlight Award Presentations | ||
| 16:45-17:00 | Sociodemographic and Clinical Variables Associated with Cannabis Use in a Community Sample of Persons Living with Chronic Pain in Quebec, Canada | Marimée Godbout-Parent, BSc |
| 17:00 | DAY 1 CLOSES | |
| 17:15-17:45 | Annual General Meeting of the CCIC | |
| Day 2: Friday April 21, 2022 | ||
| 8:00-9:00 | Breakfast | |
| SESSION 3: Medical Cannabis and Therapeutic Targets | ||
| Chair: | ||
| 9:00-10:00 | Clinician's Panel Discussion | |
| 10:00-10:20 | Dosing for Cannabinoids in the Clinic | Hance Clarke, MD, PhD, FRCPC |
| 10:20-10:50 | Cannabinoids and Drug Interactions | Maria Zhang, PharmD |
| 10:50-11:10 | Health and Coffee Break | |
| 11:10-11:40 | Cannabis in Dementia Related Agitation: Rationale and Evidence | Krista Lanctôt, PhD |
| 11:40-12:10 | Cannabis in Pediatrics | Lauren Kelly, PhD |
| 12:10-12:40 | Cannabis for Chronic Pain: Panacea or Poison? | Karim Ladha, MD, MSc, FRCPC |
| 12:40-13:45 | Lunch | |
| SESSION 4: Harm Reduction and Public Health Implications of Cannabis Legalization | ||
| Chair: | ||
| 13:45-14:30 | Cannabis Legalization 3.5 years in: Impacts From a National Policy Perspective | Rebecca Jesseman, MA |
| 14:30-14:45 | CIHR Update | Nina Cluny, PhD |
| 14:45-15:00 | Health Canada Update | George Mammen, PhD |
| 15:00-15:30 | The TRACE Project | Ana Figueras |
| 15:30-15:45 | Cannabis Use and Mental Health in Queer and Trans Youth in Quebec: Qualitative Insights | Kira London-Nadeau, MSc Connor Lafortune |
| 15:45-16:00 | Experiences in the Medical Cannabis Program in Canada | Lynda Balneaves, PhD, RN |
| 16:00-17:30 | Poster Session | |
| 17:30 | CONGRESS CLOSES |